FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026567103> ?p ?o ?g. }

• W2026567103 endingPage "561" @default.
• W2026567103 startingPage "553" @default.
• W2026567103 abstract "Introduction:Selection of antihypertensive therapy hinges on an appropriate combination of efficacy, tolerability and compatibility with co-morbidities. Within a given class of antihypertensives, the choice of agent is often driven by cost, with the cheapest appropriate agent being chosen. Amongst the angiotensin receptor blockers (ARBs), this choice will often be losartan, as it is available in generic form. However, as the blood pressure lowering efficacy of losartan is modest, some patients will require an alternative ARB. In the UK this choice is often candesartan, although the agent with greatest BP lowering efficacy is olmesartan. The objective of this study was to use a cost-benefit model to compare the costs associated with target achievement using each of these two agents, in order to guide optimum use of prescribing budgets.Method:A probabilistic cost-benefit model was constructed for a cohort of patients with moderate hypertension, based on a standardised titration and maintenance algorithm using either olmesartan or candesartan, combined with thiazide and calcium channel blocker where required. Direct treatment costs were recorded, along with the proportion of patients achieving pre-defined treatment targets at each treatment level. Results were expressed as mean treatment cost per patient reaching target.Results:Based on the current QoF target of 150 mmHg systolic, 94.3% of patients on the olmesartan-based regimen reached target of 150 mmHg, compared with 89.0% of those on the candesartan-based regimen. 86% of olmesartan patients reached target on <3 drugs, compared with 74% of candesartan patients. The mean 12-month cost per patient reaching target was £171.36 for olmesartan versus £189.91 for candesartan. Ongoing annual maintenance costs for patients at target were £169.97 and £182.64, respectively. Similar results were obtained when considering alternative treatment targetsLimitations:The study only compared two ARBs – candesartan and olmesartan and the results relate to prescribing costs only and do not include other healthcare costs. Additionally, the chosen outcome was blood pressure target achievement, rather than clinical endpoints. Given the stated objectives of the model, we do not believe these issues will have introduced bias in the direction of either comparatorConclusion:Although olmesartan has an apparently higher acquisition cost than candesartan, its superior BP lowering efficacy means that the overall cost per patient treated to target is actually lower. This result could have significant implications for making savings within primary care prescribing budgets in the UK." @default.
• W2026567103 created "2016-06-24" @default.
• W2026567103 creator A5089703907 @default.
• W2026567103 date "2011-01-01" @default.
• W2026567103 modified "2023-09-25" @default.
• W2026567103 title "Choice of angiotensin receptor blocker in moderate hypertension. A UK-based cost–benefit comparison of olmesartan- and candesartan-based regimens" @default.
• W2026567103 cites W1508421392 @default.
• W2026567103 cites W1981013062 @default.
• W2026567103 cites W2032595010 @default.
• W2026567103 cites W2035289286 @default.
• W2026567103 cites W2092249899 @default.
• W2026567103 cites W2093817793 @default.
• W2026567103 cites W2129991662 @default.
• W2026567103 cites W2133416234 @default.
• W2026567103 cites W2139480984 @default.
• W2026567103 cites W2151865548 @default.
• W2026567103 cites W2171673811 @default.
• W2026567103 cites W2172032309 @default.
• W2026567103 cites W2562329777 @default.
• W2026567103 cites W3009055627 @default.
• W2026567103 doi "https://doi.org/10.3111/13696998.2011.595463" @default.
• W2026567103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21707445" @default.
• W2026567103 hasPublicationYear "2011" @default.
• W2026567103 type Work @default.
• W2026567103 sameAs 2026567103 @default.
• W2026567103 citedByCount "4" @default.
• W2026567103 countsByYear W20265671032013 @default.
• W2026567103 countsByYear W20265671032014 @default.
• W2026567103 countsByYear W20265671032016 @default.
• W2026567103 countsByYear W20265671032017 @default.
• W2026567103 crossrefType "journal-article" @default.
• W2026567103 hasAuthorship W2026567103A5089703907 @default.
• W2026567103 hasConcept C104849204 @default.
• W2026567103 hasConcept C126322002 @default.
• W2026567103 hasConcept C197934379 @default.
• W2026567103 hasConcept C2778375690 @default.
• W2026567103 hasConcept C2779766728 @default.
• W2026567103 hasConcept C2780036600 @default.
• W2026567103 hasConcept C2780288358 @default.
• W2026567103 hasConcept C2781413609 @default.
• W2026567103 hasConcept C2908929049 @default.
• W2026567103 hasConcept C71924100 @default.
• W2026567103 hasConcept C84393581 @default.
• W2026567103 hasConcept C98274493 @default.
• W2026567103 hasConceptScore W2026567103C104849204 @default.
• W2026567103 hasConceptScore W2026567103C126322002 @default.
• W2026567103 hasConceptScore W2026567103C197934379 @default.
• W2026567103 hasConceptScore W2026567103C2778375690 @default.
• W2026567103 hasConceptScore W2026567103C2779766728 @default.
• W2026567103 hasConceptScore W2026567103C2780036600 @default.
• W2026567103 hasConceptScore W2026567103C2780288358 @default.
• W2026567103 hasConceptScore W2026567103C2781413609 @default.
• W2026567103 hasConceptScore W2026567103C2908929049 @default.
• W2026567103 hasConceptScore W2026567103C71924100 @default.
• W2026567103 hasConceptScore W2026567103C84393581 @default.
• W2026567103 hasConceptScore W2026567103C98274493 @default.
• W2026567103 hasIssue "5" @default.
• W2026567103 hasLocation W20265671031 @default.
• W2026567103 hasLocation W20265671032 @default.
• W2026567103 hasOpenAccess W2026567103 @default.
• W2026567103 hasPrimaryLocation W20265671031 @default.
• W2026567103 hasRelatedWork W137606157 @default.
• W2026567103 hasRelatedWork W1976929788 @default.
• W2026567103 hasRelatedWork W2007688337 @default.
• W2026567103 hasRelatedWork W2044256491 @default.
• W2026567103 hasRelatedWork W2082915359 @default.
• W2026567103 hasRelatedWork W2097957153 @default.
• W2026567103 hasRelatedWork W2171797634 @default.
• W2026567103 hasRelatedWork W3193972101 @default.
• W2026567103 hasRelatedWork W330879772 @default.
• W2026567103 hasRelatedWork W48752276 @default.
• W2026567103 hasVolume "14" @default.
• W2026567103 isParatext "false" @default.
• W2026567103 isRetracted "false" @default.
• W2026567103 magId "2026567103" @default.
• W2026567103 workType "article" @default.